Stock screener

NAUT

Conviction 12IndustrialsScan · Mon, Aug 10, 2026
NAUT$0.8656-3.83%
ResistanceSupportVol 14Insider sell
63 bars
12
Vol MA14 1.05M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Nautilus Biotechnology, Inc.LABORATORY ANALYTICAL INSTRUMENTSwww.nautilus.bio
Price0.8656
Change-3.83%
Gap+0.10%
Rel volume0.81×
Avg volume888.28K
Avg $ vol1.08M
SMA 201.35
SMA 501.85
SMA 2002.23
Price vs 50-53.13%
Price vs 200-61.12%
MA stackbearish
50/200 cross
Supertrenddown · 1.26
RSI (14)20
MACD hist-0.03
MACD crossbear · 9d
Stoch %K / %D3 / 4
ADX (14)44
+DI / −DI10 / 41
RSI divergenceBullish
MACD divergenceBullish
ATR %+14.98%
ADR %9.58%
52w high3.95
52w low0.6390
From 52w high-78.09%
Above 52w low+35.46%
New 52w highNo
SqueezeOff
Bollinger width109.94%
%B0.18
Donchian pos2.50%
Donchian high1.82
Donchian low0.8411
AVWAP (52w high)2.07
vs AVWAP high-58.11%
AVWAP (52w low)1.91
vs AVWAP low-54.69%
OBV trendDown
Chaikin MF (20)-0.43
Today vs 20d0.81×
Avg vol (14d)1.05M
Avg vol (20d)888.28K
Avg $ vol (20d)1.08M
Market cap110M
RS 3m (vs SPY)-74.44%
RS 6m (vs SPY)-69.55%
RS line new highNo
Trend template3/8
Technical rank2.5
1 week-14.30%
1 month-54.20%
3 months-67.70%
6 months-57.36%
1 year+16.22%
YTD-54.68%
P/E-1.86
P/B0.76
P/S
P/FCF-2.12
EPS-0.4700
Div yield
ROE-40.86%
ROA-33.19%
Debt/Eq
Current11.85
EV/EBITDA
Gross margin
Net margin
Rev growth
EPS growth16.64%
Price target
Target upside
Analyst rating
Institutional
Ent. value95.37M
Revenue
Net income-14.7M
Gross profit
Free cash flow-51.97M
IndustryLABORATORY ANALYTICAL INSTRUMENTS
ExchangeNasdaq
Shares out127.08M
Employees130
ListedThu, Jun 10, 2021
Free float34.72M
Float %27.4%
Short interest1.45M
Days to cover1.3d
Short volume51.4%
Squeeze score22 / 100
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeD
Conviction12 / 100
Pattern quality
Tech rank2.5 / 100
Group rank68 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance2.26
Support1.26
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NAUT

All disclosures →
No recent disclosed trades by Congress in NAUT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NAUT · 5 buys · 5 sells

InsiderSideShares
NAZEM FARZAD
Director · Stock Option (Right to Buy) · 2026-06-18
Grant45K
Posard Matthew L.
Director · Stock Option (Right to Buy) · 2026-06-18
Grant45K
Akinsanya Karen
Director · Stock Option (Right to Buy) · 2026-06-18
Grant45K
McIlwain Matthew S
Director · Stock Option (Right to Buy) · 2026-06-18
Grant45K
Epperly Melissa B,
Director · Stock Option (Right to Buy) · 2026-06-18
Grant45K
HOROWITZ BENJAMIN A
10% owner · Common Stock · 2026-06-02
Sell384.03K
AH Equity Partners Bio II, L.L.C.
10% owner · Common Stock · 2026-06-02
Sell384.03K
AH Equity Partners LSV II, L.L.C.
10% owner · Common Stock · 2026-06-02
Sell384.03K
AH Bio Fund II, L.P.
10% owner · Common Stock · 2026-06-02
Sell384.03K
Andreessen Horowitz LSV Fund II, L.P.
10% owner · Common Stock · 2026-06-02
Sell384.03K

SEC filings

EDGAR filings in NAUT · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.